biosimilars

FDA approves biosimilar to HumiraFDA’s pace of biosimilar approvals is picking up, as it approved two major drugs for rheumatoid arthritis and other inflammatory diseases in the past month.
FDA approves etanercept biosimilar for psoriasis, psoriatic arthritisThe FDA approved the biosimilars Erelzi for plaque psoriasis and Enbrel for psoriatic arthritis.